These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32098730)

  • 1. Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System.
    Loeb S; Byrne NK; Wang B; Makarov DV; Becker D; Wise DR; Lepor H; Walter D
    Eur Urol; 2020 Jun; 77(6):683-686. PubMed ID: 32098730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018.
    Parikh RB; Robinson KW; Chhatre S; Medvedeva E; Cashy JP; Veera S; Bauml JM; Fojo T; Navathe AS; Malkowicz SB; Mamtani R; Jayadevappa R
    JAMA Netw Open; 2020 Sep; 3(9):e2018318. PubMed ID: 32986109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.
    Loeb S; Byrne N; Makarov DV; Lepor H; Walter D
    JAMA; 2018 Jun; 319(21):2231-2233. PubMed ID: 29800017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Guideline-Discordant Prostate Cancer Imaging Rates and Health Care Service Among Veterans and Medicare Recipients.
    Makarov DV; Ciprut S; Walter D; Kelly M; Gold HT; Zhou XH; Sherman SE; Braithwaite RS; Gross C; Zeliadt S
    JAMA Netw Open; 2018 Aug; 1(4):e181172. PubMed ID: 30646111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay.
    Lynch JA; Rothney MP; Salup RR; Ercole CE; Mathur SC; Duchene DA; Basler JW; Hernandez J; Liss MA; Porter MP; Wright JL; Risk MC; Garzotto M; Efimova O; Barrett L; Berse B; Kemeter MJ; Febbo PG; Dash A
    Am J Manag Care; 2018 Jan; 24(1 Suppl):S4-S10. PubMed ID: 29337486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States.
    Al Hussein Al Awamlh B; Ma X; Scherr D; Hu JC; Shoag JE
    Urology; 2020 Mar; 137():60-65. PubMed ID: 31948677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database.
    Mahal AR; Butler S; Franco I; Muralidhar V; Larios D; Pike LRG; Zhao SG; Sanford NN; Dess RT; Feng FY; D'Amico AV; Spratt DE; Yu JB; Nguyen PL; Rebbeck TR; Mahal BA
    Cancer; 2019 Oct; 125(19):3338-3346. PubMed ID: 31251398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016.
    Ong WL; Evans SM; Evans M; Tacey M; Dodds L; Kearns P; Milne RL; Foroudi F; Millar J
    Eur Urol Oncol; 2021 Apr; 4(2):319-322. PubMed ID: 31411964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of prostate cancer care among rural men in the Veterans Health Administration.
    Skolarus TA; Chan S; Shelton JB; Antonio AL; Sales AE; Malin JL; Saigal CS
    Cancer; 2013 Oct; 119(20):3629-35. PubMed ID: 23913676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort.
    Tosoian JJ; Mamawala M; Epstein JI; Landis P; Macura KJ; Simopoulos DN; Carter HB; Gorin MA
    Eur Urol; 2020 Jun; 77(6):675-682. PubMed ID: 31918957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Receipt of Positron Emission Tomography-Computed Tomography With Non-Small Cell Lung Cancer Mortality in the Veterans Affairs Health Care System.
    Vella M; Meyer CS; Zhang N; Cohen BE; Whooley MA; Wang S; Hope MD
    JAMA Netw Open; 2019 Nov; 2(11):e1915828. PubMed ID: 31747036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Trends and Site Variation in High-Risk Coronary Intervention and the Use of Mechanical Circulatory Support: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program.
    Bricker RS; Glorioso TJ; Jawaid O; Plomondon ME; Valle JA; Armstrong EJ; Waldo SW
    J Am Heart Assoc; 2019 Dec; 8(24):e014906. PubMed ID: 31813312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.
    Loeb S; Zhou Q; Siebert U; Rochau U; Jahn B; Mühlberger N; Carter HB; Lepor H; Braithwaite RS
    Eur Urol; 2017 Dec; 72(6):899-907. PubMed ID: 28844371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.
    Sathianathen NJ; Konety BR; Alarid-Escudero F; Lawrentschuk N; Bolton DM; Kuntz KM
    Eur Urol; 2019 Jun; 75(6):910-917. PubMed ID: 30425010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care providers' attitudes toward prostate cancer risk factors at a Veterans Affairs health care facility.
    Ruff PA; Marotte JB; Terris MK
    Mil Med; 2005 Feb; 170(2):154-7. PubMed ID: 15782838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study.
    Siston AK; Knight SJ; Slimack NP; Chmiel JS; Nadler RB; Lyons TM; Kuzel TM; Moran EM; Sharifi R; Bennett CL;
    Urology; 2003 Jan; 61(1):172-8. PubMed ID: 12559291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
    Loeb S; Berglund A; Stattin P
    J Urol; 2013 Nov; 190(5):1742-9. PubMed ID: 23727309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J
    JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients.
    Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
    Eur Urol Oncol; 2019 Sep; 2(5):483-489. PubMed ID: 31411970
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.